Mark Dybul
Directeur Général chez RENOVARO INC.
Fortune : 113 018 $ au 30/04/2024
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Tracy Marie Blackwell | F | 56 |
Elton John AIDS Foundation
Elton John AIDS Foundation Miscellaneous Commercial ServicesCommercial Services The Elton John AIDS Foundation is a leading independent AIDS charity that aims to end the AIDS epidemic. The non-profit company is based in London, UK. The foundation mobilizes a network of generous supporters and partners to fund local experts across four continents to challenge discrimination, prevent infections, and provide treatment. Founded by Sir Elton John in 1992, the foundation has raised over $525 million to fund evidence-based frontline programs and policies, combat stigma, prevent infections, provide treatment and services, and motivate governments to end AIDS. The CEO is Anne Aslett.
Elton John AIDS Foundation, Inc.
Elton John AIDS Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services Elton John AIDS Foundation, Inc. provides services to people living with HIV/AIDS and educational programs targeted at HIV/AIDS prevention. The company was founded by Elton John in 1992 and is headquartered in New York, NY. | - |
Rene Sindlev | M | 61 | 13 ans | |
Mark Feinberg | M | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Anne Aslett | F | - |
Elton John AIDS Foundation
Elton John AIDS Foundation Miscellaneous Commercial ServicesCommercial Services The Elton John AIDS Foundation is a leading independent AIDS charity that aims to end the AIDS epidemic. The non-profit company is based in London, UK. The foundation mobilizes a network of generous supporters and partners to fund local experts across four continents to challenge discrimination, prevent infections, and provide treatment. Founded by Sir Elton John in 1992, the foundation has raised over $525 million to fund evidence-based frontline programs and policies, combat stigma, prevent infections, provide treatment and services, and motivate governments to end AIDS. The CEO is Anne Aslett.
Elton John AIDS Foundation, Inc.
Elton John AIDS Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services Elton John AIDS Foundation, Inc. provides services to people living with HIV/AIDS and educational programs targeted at HIV/AIDS prevention. The company was founded by Elton John in 1992 and is headquartered in New York, NY. | - |
Eric Paul Goosby | M | - |
Elton John AIDS Foundation, Inc.
Elton John AIDS Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services Elton John AIDS Foundation, Inc. provides services to people living with HIV/AIDS and educational programs targeted at HIV/AIDS prevention. The company was founded by Elton John in 1992 and is headquartered in New York, NY.
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | 11 ans |
Jayne McNicol | F | 57 | 3 ans | |
John Ronald Bergius | M | - |
Elton John AIDS Foundation
Elton John AIDS Foundation Miscellaneous Commercial ServicesCommercial Services The Elton John AIDS Foundation is a leading independent AIDS charity that aims to end the AIDS epidemic. The non-profit company is based in London, UK. The foundation mobilizes a network of generous supporters and partners to fund local experts across four continents to challenge discrimination, prevent infections, and provide treatment. Founded by Sir Elton John in 1992, the foundation has raised over $525 million to fund evidence-based frontline programs and policies, combat stigma, prevent infections, provide treatment and services, and motivate governments to end AIDS. The CEO is Anne Aslett.
Elton John AIDS Foundation, Inc.
Elton John AIDS Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services Elton John AIDS Foundation, Inc. provides services to people living with HIV/AIDS and educational programs targeted at HIV/AIDS prevention. The company was founded by Elton John in 1992 and is headquartered in New York, NY. | - |
David Furnish | M | 62 |
Elton John AIDS Foundation
Elton John AIDS Foundation Miscellaneous Commercial ServicesCommercial Services The Elton John AIDS Foundation is a leading independent AIDS charity that aims to end the AIDS epidemic. The non-profit company is based in London, UK. The foundation mobilizes a network of generous supporters and partners to fund local experts across four continents to challenge discrimination, prevent infections, and provide treatment. Founded by Sir Elton John in 1992, the foundation has raised over $525 million to fund evidence-based frontline programs and policies, combat stigma, prevent infections, provide treatment and services, and motivate governments to end AIDS. The CEO is Anne Aslett.
Elton John AIDS Foundation, Inc.
Elton John AIDS Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services Elton John AIDS Foundation, Inc. provides services to people living with HIV/AIDS and educational programs targeted at HIV/AIDS prevention. The company was founded by Elton John in 1992 and is headquartered in New York, NY. | - |
Jamie Cooper | F | - |
Big Win Philanthropy
Big Win Philanthropy Miscellaneous Commercial ServicesCommercial Services Big Win Philanthropy is an organization that partners with African leaders to improve the lives of children and young people. The non-profit company is based in London, UK, and was founded in 2015. The British company seeks to build demographic dividends for equitable economic growth, peace, and security. The organization has partnered with the N Centre for Cities on a ground-breaking initiative to catalyze the transformation of cities in Africa. The company has also partnered with the government of Côte d'Ivoire to accelerate the creation of job opportunities for young people. The CEO is Kesetebirhan Admasu. | - |
Richard Reger | M | - |
Elton John AIDS Foundation, Inc.
Elton John AIDS Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services Elton John AIDS Foundation, Inc. provides services to people living with HIV/AIDS and educational programs targeted at HIV/AIDS prevention. The company was founded by Elton John in 1992 and is headquartered in New York, NY. | - |
Robert Goldberg | M | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
François Binette | M | - | 2 ans | |
Carol Brosgart | M | 72 | 5 ans | |
Rudolphus Gabriel Cornelis Hendriks | M | 78 | 1 ans | |
Hilde Frafjord Johnson | F | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Ilana Kloss | F | 68 |
Elton John AIDS Foundation
Elton John AIDS Foundation Miscellaneous Commercial ServicesCommercial Services The Elton John AIDS Foundation is a leading independent AIDS charity that aims to end the AIDS epidemic. The non-profit company is based in London, UK. The foundation mobilizes a network of generous supporters and partners to fund local experts across four continents to challenge discrimination, prevent infections, and provide treatment. Founded by Sir Elton John in 1992, the foundation has raised over $525 million to fund evidence-based frontline programs and policies, combat stigma, prevent infections, provide treatment and services, and motivate governments to end AIDS. The CEO is Anne Aslett.
Elton John AIDS Foundation, Inc.
Elton John AIDS Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services Elton John AIDS Foundation, Inc. provides services to people living with HIV/AIDS and educational programs targeted at HIV/AIDS prevention. The company was founded by Elton John in 1992 and is headquartered in New York, NY. | 6 ans |
Greg Duczynski | M | - | 8 ans | |
James Sapirstein | M | 63 | 6 ans | |
Labeeb M. Abboud | M | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Leni M. T. Boeren | F | 60 | 1 ans | |
Gregg Alton | M | 58 | 4 ans | |
John Nkengasong | M | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Virginia Banks | F | - |
Elton John AIDS Foundation, Inc.
Elton John AIDS Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services Elton John AIDS Foundation, Inc. provides services to people living with HIV/AIDS and educational programs targeted at HIV/AIDS prevention. The company was founded by Elton John in 1992 and is headquartered in New York, NY. | - |
Linda-Gail Bekker | F | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Nikolaos Makris | M | 56 |
Big Win Philanthropy
Big Win Philanthropy Miscellaneous Commercial ServicesCommercial Services Big Win Philanthropy is an organization that partners with African leaders to improve the lives of children and young people. The non-profit company is based in London, UK, and was founded in 2015. The British company seeks to build demographic dividends for equitable economic growth, peace, and security. The organization has partnered with the N Centre for Cities on a ground-breaking initiative to catalyze the transformation of cities in Africa. The company has also partnered with the government of Côte d'Ivoire to accelerate the creation of job opportunities for young people. The CEO is Kesetebirhan Admasu. | - |
John Barbis | M | - |
Elton John AIDS Foundation, Inc.
Elton John AIDS Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services Elton John AIDS Foundation, Inc. provides services to people living with HIV/AIDS and educational programs targeted at HIV/AIDS prevention. The company was founded by Elton John in 1992 and is headquartered in New York, NY. | - |
Emma Kane | F | - |
Elton John AIDS Foundation, Inc.
Elton John AIDS Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services Elton John AIDS Foundation, Inc. provides services to people living with HIV/AIDS and educational programs targeted at HIV/AIDS prevention. The company was founded by Elton John in 1992 and is headquartered in New York, NY. | - |
Brian Graden | M | - |
Elton John AIDS Foundation, Inc.
Elton John AIDS Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services Elton John AIDS Foundation, Inc. provides services to people living with HIV/AIDS and educational programs targeted at HIV/AIDS prevention. The company was founded by Elton John in 1992 and is headquartered in New York, NY. | - |
Matt Blinstrubas | M | - |
Elton John AIDS Foundation, Inc.
Elton John AIDS Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services Elton John AIDS Foundation, Inc. provides services to people living with HIV/AIDS and educational programs targeted at HIV/AIDS prevention. The company was founded by Elton John in 1992 and is headquartered in New York, NY. | - |
Ana Cespedes | M | 51 |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Lynda Baker Funke | F | - |
Elton John AIDS Foundation
Elton John AIDS Foundation Miscellaneous Commercial ServicesCommercial Services The Elton John AIDS Foundation is a leading independent AIDS charity that aims to end the AIDS epidemic. The non-profit company is based in London, UK. The foundation mobilizes a network of generous supporters and partners to fund local experts across four continents to challenge discrimination, prevent infections, and provide treatment. Founded by Sir Elton John in 1992, the foundation has raised over $525 million to fund evidence-based frontline programs and policies, combat stigma, prevent infections, provide treatment and services, and motivate governments to end AIDS. The CEO is Anne Aslett. | 6 ans |
Anne M. Simonds | F | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Wendy Chung | M | 55 |
National Academy of Medicine
| - |
John Z. Ayanian | M | - |
National Academy of Medicine
| - |
Francine Ntoumi | F | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Suprotik Basu | M | 47 |
Big Win Philanthropy
Big Win Philanthropy Miscellaneous Commercial ServicesCommercial Services Big Win Philanthropy is an organization that partners with African leaders to improve the lives of children and young people. The non-profit company is based in London, UK, and was founded in 2015. The British company seeks to build demographic dividends for equitable economic growth, peace, and security. The organization has partnered with the N Centre for Cities on a ground-breaking initiative to catalyze the transformation of cities in Africa. The company has also partnered with the government of Côte d'Ivoire to accelerate the creation of job opportunities for young people. The CEO is Kesetebirhan Admasu. | - |
Cristina de Albuquerque Possas | F | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Emma Kane | F | 57 |
Elton John AIDS Foundation
Elton John AIDS Foundation Miscellaneous Commercial ServicesCommercial Services The Elton John AIDS Foundation is a leading independent AIDS charity that aims to end the AIDS epidemic. The non-profit company is based in London, UK. The foundation mobilizes a network of generous supporters and partners to fund local experts across four continents to challenge discrimination, prevent infections, and provide treatment. Founded by Sir Elton John in 1992, the foundation has raised over $525 million to fund evidence-based frontline programs and policies, combat stigma, prevent infections, provide treatment and services, and motivate governments to end AIDS. The CEO is Anne Aslett. | - |
David Apuuli | M | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Joseph R. Cohen | M | - | - | |
Chris Klatell | M | - |
Big Win Philanthropy
Big Win Philanthropy Miscellaneous Commercial ServicesCommercial Services Big Win Philanthropy is an organization that partners with African leaders to improve the lives of children and young people. The non-profit company is based in London, UK, and was founded in 2015. The British company seeks to build demographic dividends for equitable economic growth, peace, and security. The organization has partnered with the N Centre for Cities on a ground-breaking initiative to catalyze the transformation of cities in Africa. The company has also partnered with the government of Côte d'Ivoire to accelerate the creation of job opportunities for young people. The CEO is Kesetebirhan Admasu. | - |
Kesetebirhan Admasu | M | - |
Big Win Philanthropy
Big Win Philanthropy Miscellaneous Commercial ServicesCommercial Services Big Win Philanthropy is an organization that partners with African leaders to improve the lives of children and young people. The non-profit company is based in London, UK, and was founded in 2015. The British company seeks to build demographic dividends for equitable economic growth, peace, and security. The organization has partnered with the N Centre for Cities on a ground-breaking initiative to catalyze the transformation of cities in Africa. The company has also partnered with the government of Côte d'Ivoire to accelerate the creation of job opportunities for young people. The CEO is Kesetebirhan Admasu. | - |
Dzingai Mutumbuka | M | 79 |
Big Win Philanthropy
Big Win Philanthropy Miscellaneous Commercial ServicesCommercial Services Big Win Philanthropy is an organization that partners with African leaders to improve the lives of children and young people. The non-profit company is based in London, UK, and was founded in 2015. The British company seeks to build demographic dividends for equitable economic growth, peace, and security. The organization has partnered with the N Centre for Cities on a ground-breaking initiative to catalyze the transformation of cities in Africa. The company has also partnered with the government of Côte d'Ivoire to accelerate the creation of job opportunities for young people. The CEO is Kesetebirhan Admasu. | - |
Michelle Harrison | F | 56 |
Big Win Philanthropy
Big Win Philanthropy Miscellaneous Commercial ServicesCommercial Services Big Win Philanthropy is an organization that partners with African leaders to improve the lives of children and young people. The non-profit company is based in London, UK, and was founded in 2015. The British company seeks to build demographic dividends for equitable economic growth, peace, and security. The organization has partnered with the N Centre for Cities on a ground-breaking initiative to catalyze the transformation of cities in Africa. The company has also partnered with the government of Côte d'Ivoire to accelerate the creation of job opportunities for young people. The CEO is Kesetebirhan Admasu. | - |
Anjali Gopalan | F | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Li-Huei Tsai | M | 64 |
National Academy of Medicine
| - |
Barney Graham | M | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Bill Haney | M | - |
Big Win Philanthropy
Big Win Philanthropy Miscellaneous Commercial ServicesCommercial Services Big Win Philanthropy is an organization that partners with African leaders to improve the lives of children and young people. The non-profit company is based in London, UK, and was founded in 2015. The British company seeks to build demographic dividends for equitable economic growth, peace, and security. The organization has partnered with the N Centre for Cities on a ground-breaking initiative to catalyze the transformation of cities in Africa. The company has also partnered with the government of Côte d'Ivoire to accelerate the creation of job opportunities for young people. The CEO is Kesetebirhan Admasu. | - |
Luísa Dias Diogo | F | - |
Big Win Philanthropy
Big Win Philanthropy Miscellaneous Commercial ServicesCommercial Services Big Win Philanthropy is an organization that partners with African leaders to improve the lives of children and young people. The non-profit company is based in London, UK, and was founded in 2015. The British company seeks to build demographic dividends for equitable economic growth, peace, and security. The organization has partnered with the N Centre for Cities on a ground-breaking initiative to catalyze the transformation of cities in Africa. The company has also partnered with the government of Côte d'Ivoire to accelerate the creation of job opportunities for young people. The CEO is Kesetebirhan Admasu. | - |
Malik Dechambenoit | M | - |
Big Win Philanthropy
Big Win Philanthropy Miscellaneous Commercial ServicesCommercial Services Big Win Philanthropy is an organization that partners with African leaders to improve the lives of children and young people. The non-profit company is based in London, UK, and was founded in 2015. The British company seeks to build demographic dividends for equitable economic growth, peace, and security. The organization has partnered with the N Centre for Cities on a ground-breaking initiative to catalyze the transformation of cities in Africa. The company has also partnered with the government of Côte d'Ivoire to accelerate the creation of job opportunities for young people. The CEO is Kesetebirhan Admasu. | - |
Thomas Richie | M | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Susan Silbermann | F | 61 |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Richard Berman | M | 79 |
National Academy of Medicine
| - |
Randall Kaja | M | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
John Shiver | M | 66 |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | 6 ans |
Andrew Pecora | M | 67 |
Georgetown University Medical Center
| - |
Ulysee Huling | M | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Sandi Glass | F | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Eneide Geiyer | F | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Steven P. Fling | M | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Patricia Fast | M | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Joanne P. Alicea | F | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Lisa Beyer | F | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | 17 ans |
Louis D. Schwartz | M | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Julian Lob-Levyt | M | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Geeta Rao Gupta | M | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Jaap Goudsmit | M | 73 |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Vassilios Papadopoulos | M | 63 |
Georgetown University Medical Center
| - |
Michèle Barzach | M | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Anne VanLent | F | 76 |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | 16 ans |
Avram Miller | M | - | 1 ans | |
David Leslie Blumberg | M | 62 |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Paul Schimmel | M | 83 |
National Academy of Medicine
| - |
Michel Kazatchkine | M | 77 |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Rachel Steinhardt | F | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Ajaz Khowaj Quoram Ahmed | M | 51 |
Elton John AIDS Foundation
Elton John AIDS Foundation Miscellaneous Commercial ServicesCommercial Services The Elton John AIDS Foundation is a leading independent AIDS charity that aims to end the AIDS epidemic. The non-profit company is based in London, UK. The foundation mobilizes a network of generous supporters and partners to fund local experts across four continents to challenge discrimination, prevent infections, and provide treatment. Founded by Sir Elton John in 1992, the foundation has raised over $525 million to fund evidence-based frontline programs and policies, combat stigma, prevent infections, provide treatment and services, and motivate governments to end AIDS. The CEO is Anne Aslett. | 5 ans |
Anthony Musyoka | M | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Bonnie Bender | F | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | 21 ans |
Paul Buccieri | M | 58 |
Elton John AIDS Foundation, Inc.
Elton John AIDS Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services Elton John AIDS Foundation, Inc. provides services to people living with HIV/AIDS and educational programs targeted at HIV/AIDS prevention. The company was founded by Elton John in 1992 and is headquartered in New York, NY. | 1 ans |
Purnima Mane | M | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | 12 ans |
Marijke Wijnroks | F | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Raju S. Kucherlapati | M | 81 |
National Academy of Medicine
| 16 ans |
Dianne Stewart | F | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Holly Wong | F | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Shudo Yamazaki | M | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Philip K. Russell | M | 91 |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Malegapuru William Makgoba | M | 72 |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Chrispus Kiyonga | M | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Glenys Kinnock | M | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Angela Gómez de Mogollón | F | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Richard G. A. Feachem | M | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Rajeev Venkayya | M | - |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | - |
Jaime Sepulveda | M | 70 |
National Academy of Medicine
| - |
Evgeny Lebedev | M | - |
Elton John AIDS Foundation
Elton John AIDS Foundation Miscellaneous Commercial ServicesCommercial Services The Elton John AIDS Foundation is a leading independent AIDS charity that aims to end the AIDS epidemic. The non-profit company is based in London, UK. The foundation mobilizes a network of generous supporters and partners to fund local experts across four continents to challenge discrimination, prevent infections, and provide treatment. Founded by Sir Elton John in 1992, the foundation has raised over $525 million to fund evidence-based frontline programs and policies, combat stigma, prevent infections, provide treatment and services, and motivate governments to end AIDS. The CEO is Anne Aslett. | - |
Lester Russell | M | - | 1 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Luisa Puche | F | 61 | 5 ans | |
Robert Wolfe | M | 61 | 2 ans | |
Henrik Grønfeldt-Sørensen | M | 51 | 7 ans | |
Carl Sandler | M | 51 | 4 ans |
Statistiques
Pays | Relations | % du total |
---|---|---|
Etats-Unis | 78 | 78,79% |
Royaume-Uni | 19 | 19,19% |
Roumanie | 7 | 7,07% |
Suisse | 0 | -.--% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Mark Dybul
- Réseau Personnel